RF
JAZZ icon

Rossby Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rossby Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Buy
86
+2
+2% +$438 ﹤0.01% 952
2026
Q1 		$15.8K Buy
84
+24
+40% +$4.19K ﹤0.01% 1087
2025
Q4 		$10.2K Buy
60
+5
+9% +$767 ﹤0.01% 921
2025
Q3 		$7.53K Sell
55
-1,105
-95% -$133K ﹤0.01% 913
2025
Q2 		$123K Buy
1,160
+17
+1% +$1.85K 0.05% 333
2025
Q1 		$127K Buy
+1,143
New +$149K 0.05% 306

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Rossby Financial's JAZZ Position: Q2 2026 in Review

Rossby Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 2.4% in Q2 2026, buying an estimated $438 and bringing the position to 86 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Rossby Financial first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $127K in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Rossby Financial held 86 shares of Jazz Pharmaceuticals worth $20.7K as of Q2 2026.
  • Rossby Financial bought 2 Jazz Pharmaceuticals shares in Q2 2026, an estimated $438.
  • Jazz Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #952 holding.
  • Rossby Financial first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Rossby Financial's Jazz Pharmaceuticals position peaked at $127K in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.